Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Delhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare complaint Ruchika Sharma15 April 2025 12:49 PM ISTNew Delhi: Acting on a complaint filed by pharmaceutical major Zydus Healthcare Limited, the Drugs Control Department of the Delhi government has...
Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
Zydus Healthcare Gets CDSCO Panel Nod To study Vilanterol plus Umeclidinium powder for inhalation Dr. Divya Colin9 April 2025 6:00 PM ISTNew Delhi: Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
CDSCO Panel suggests revising phase III CT protocol of Zydus Healthcare's Empagliflozin plus Metoprolol Succinate FDC Dr. Divya Colin15 March 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report presented by Zydus Healthcare for the fixed dose combination of empagliflozin plus...
CDSCO Panel rejects Zydus Healthcare's proposal to waive Phase III CT of Diphenhydramine, Phenylephrine FDC Dr. Divya Colin30 Dec 2024 5:45 PM ISTNew Delhi: Denying the proposal for a phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on FDC Dextromethorphan, Phenylephrine Syrup Dr. Divya Colin20 Dec 2024 6:00 PM ISTNew Delhi: Reviewing the justification for the Phase III clinical trial of Zydus Healthcare's fixed dose combination (FDC) pulmonary drug...
Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol metered dose inhalation Dr. Divya Colin24 Nov 2024 5:30 PM ISTNew Delhi: Considering the bioequivalence study report presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central...
Delhi HC Grants Relief to Zydus in BIOCHEM Trademark Dispute Farhat Nasim18 Nov 2024 3:28 PM ISTNew Delhi: In relief to Zydus Healthcare, the Delhi High Court has granted an injunction restraining Alder Biochem Pvt. Ltd. from using the trademark...
Submit active controlled CT design for moderate to very severe COPD patients: CDSCO Panel tells Zydus Healthcare on Revefenacin inhalation Dr. Divya Colin16 Nov 2024 6:00 PM ISTNew Delhi: Responding to Zydus Healthcare's proposal to manufacture and market Revefenacin Inhalation Solution 175 mcg/3ml, the Subject Expert...
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Roshni Dhar28 Dec 2023 5:51 PM ISTZydus Lifesciences on Tuesday said its arm Zydus Healthcare Ltd has been served an income tax notice demand of Rs 284.58 crore for the assessment year...
Health Bulletin 28/December/2023 Roshni Dhar28 Dec 2023 4:16 PM ISTHere are the top health stories for the day:Delhi: CISF seizes medicines worth Rs 80 lakh at IGI airport, two heldTwo international passengers were...
